Journals / Türk Fertilite Dergisi / 2005 / Cilt: 13 - Sayı: 1

To evaluate the histopathological effects of various doses of clomiphene citrate on ovary in a rat model

Klomifen sitratın rat over dokusu üzerine olan etkileri

Pages
28–31
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: We did not find an association between the use of clomiphene and ovarian neoplasm; nevertheless, we noticed an increase in granulosa cell with high doses of clomiphene, which is a risk factor for granulosa cell tumours.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In the present study it was aimed to find out the possible effects of various doses ofclomiphene citrate on ovary in a rat model.
📊
Key Findings & Data:Materials and Methods: Forty female Wistar albino rats weighting 200 to 250 grams were used.
💡
Conclusion & Impact:Conclusions: We did not find an association between the use of clomiphene and ovarian neoplasm; nevertheless, we noticed an increase in granulosa cell with high doses of clomiphene, which is a risk factor for granulosa cell tumours.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In the present study it was aimed to find out the possible effects of various doses ofclomiphene citrate on ovary in a rat model. Institution: Department of Obstetrics and Gynecology and Departments of Family Medicine, Cumhuriyet University School of Medicine and Departments of Pathology, I. Izzetin Keykavus Health Ministry Hospital, Sivas. Materials and Methods: Forty female Wistar albino rats weighting 200 to 250 grams were used. The rats were assigned randomly into four groups of 10 rats each, three Clomiphene and one control groups. While clomiphene was applied to first three group of the rats, only serum physiologic was applied in the control group. Six cyclus of rats clomiphene were applied. Six months later, all rats dislocated and ovaries of the rats in four groups were excised for the histopathological assessment. A pathologist blinded to the groups made histopathological examination counting the granulose cell, thecal cell and luteal cell in each ovary. Re¬sults were evaluated with Kruskall- Wallis analysis. Results: We found a statistically significant association between the group 3 and controls related to the granulosa cell (p0.05). We found an increase in granulosa cell in the clomiphene 200-mg group. Conclusions: We did not find an association between the use of clomiphene and ovarian neoplasm; nevertheless, we noticed an increase in granulosa cell with high doses of clomiphene, which is a risk factor for granulosa cell tumours.

Özet

Amaç: Bu çalışmada klomifen sitratın insanlarda kullanılan çeşitli doz protokollerinin, raflarda uygulanması sonrası, over dokusunda meydana getirdiği histopatolojik değişiklikleri araştırmak ve doza bağımlı, karşılaştırma yapmak amaçlanmıştır. Çalışmanın yapıldığı yer: Cumhuriyet Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Anabilim Dalı, Cumhuriyet Üniversitesi Tıp Fakültesi Aile Hekimliği Anabilim Dalı.Sivas ve I. izzetin Keykavus Devlet Hastanesi Patoloji Servisi, Sivas. Materyal ve Metod: Wistar'albino tipi 40 adet dişi rat 10 rattan oluşan dört gruba ayrıldı, insanlarda kullanılan 50mg/gün, lOOmg/gün ve 200mg/gün olan ovulasyon indüksiyon protokolleri ratlara göre ağırlık-doz hesabı yapılarak distile su ile karıştırılıp homojen hale getirildikten sonra, sırayla üç gruba ve kontrol grubuna ise 2cc serum fizyolojik intraperitoneal injeksiyon yijjntemi ile 5 gün süre ile, toplam 6 kez uygulandı. 6 ay sonrasında servikal dislokasyon yön¬temi ile öldürülen ratlara ooferektomi yapılarak alınan do¬kular içerisinde formol bulunan kaplarda patolojik incele¬me için saklandı. Bir patolog tarafından kör olarak grupların histopatolojik değerlendirmesi yapıldı ve her overde granüloza, teka ve luteal hücreler sayıldı. Sonuçlar Kruskall-Wallis analiziyle değerlendirildi. Bulgular: Yapılan patolojik inceleme sonrası gruplar granüloza hücresi yönünden ikişerli olarak karşılaştırıldığında kontrol grubu ile l.vel. grup arasında anlamlı fark bulunmadı (P>0,05). Kontrol grubu ile 3.grup arasında ise granüloza hücresi açısından fark anlamlı olarak bulundu (P0,05). Sonuç: Bulgularımız klomifen sitratın doza bağımlı olarak rat over dokusu hücrelerinde ovaryan neoplazi oluşturmasa bile anlamlı histopatolojik değişikliğe neden oldu¬ğunu düşündürmektedir.

🔖

Cite This Article

DEMİREL, Y., DURAN, B., TİMUROĞLU, Y., TİMUROĞLU, T., BEKAR, A., ÇETİN, M. (2022). To evaluate the histopathological effects of various doses of clomiphene citrate on ovary in a rat model. Türk Fertilite Dergisi, Cilt: 13 - Sayı: 1, 28–31. https://ajindex.com/articles/623341

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Franco C, Coppola S, Prosperi Porta R, Patella A. Ovulation induction and the risk of ovarian tumors. Minerva Ginecol. 2000 Apr;52(4):103-9
  2. S. Franks, J. Adams, H. Mason, D. Polson. Ovulatory disorders in women with polycyctic ovary syndrome. Clin Obstet Gynecol. 1985;12:605-632
  3. Derman SG, Adashi EY. Adverse effects of fertility drugs. Drug Saf. 1994 Dec;11(6):408-21
  4. Kosec V, Bukovic D, Grubisic G, Fures R. Ovarian cancer and ovulation induction drugsÑis there a link? Coll Antropol. 1999 Dec;23(2):633-9
  5. Kashyap S, Davis OK. Ovarian cancer and fertility medications: a critical appraisal. Semin Reprod Med. 2003 Feb;21(1):65-71
  6. Hull ME, Kriner M, Schneider E, Maiman M. Ovarian cancer after successful ovulation induction: a case report. Reprod Med. 1996 Jan;41(1):52-4
  7. Bristow RE, Karlan BY. Ovulation induction, infertility, and ovarian cancer risk. Fertil Steril 1996; 66: 499-507
  8. V. Terry, C.R. Murphy and C.D. Shorey. Clomiphene citrate alters vaginal surface morphology in cycling rats. Acta Anat. 1992;145:212-215
  9. J.F. Kerin, J.H. Liu, G. Phillipou and S.S. Yen. Evidence for a hypothalamic site of action of clomiphene citrate in women. J Clin Endocrinol Metab. 1985;61:265-268
  10. T.J. Mikkelson, P.D. Kroboth, W.J. Cameron. Singledose pharmacokinetics of clomiphene citrate in normal volunteers. Fertil Steril. 1986;46:392-396
  11. Fertility drugs and ovarian cancer. International Fede- ration of Fertility Societies (IFFS). Fertility drugs and ovarian cancer. Fertil Steril 1993; 60: 406-408
  12. Franceschi S, La Vecchia C, Negri E, et al. Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod 1994; 9: 1673-1675
  13. Unkila-Kallio L, Leminen A, Tiitinen A, Ylikorkala O. Nationwide data on falling incidence of ovarian granulosa cell tumours concomitant with increasing use of ovulation inducers. Hum Reprod 1998; 13: 2828-2830
  14. Unkila-Kallio L, Tiitinen A, Wahlstrom T, Lehtovirta P, Leminen A. Reproductive features in women developing ovarian granulosa cell tumour at a fertile age. Hum Reprod 2000; 15: 589-893
  15. Gocze P, Krommer K, Csermely T, et al. Ovulation induction therapy and malignant ovarian cancer. Orv Hetil 2000; 141: 71-75
  16. Nasseri S, Ledger WL. Clomiphene citrate in the twenty- first century. Hum Fertil (Camb) 2001; 4: 145-151
  17. Whittemore AS, Harris R, Itnyre J, The Collaborative Ovarian Cancer Group. Characteristics related to ovarian cancer risk: collaborative analysis of twelve US c